David Sourdive
Founder bij CELLECTIS S.A.
Vermogen: 3 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van David Sourdive
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 48 | |
Elaia Partners SAS
 Elaia Partners SAS Investment ManagersFinance Elaia Partners SAS (Elaia) is an independent French private equity boutique which was founded in 2002. Named after the Greek word for olive tree, the symbol of resilience, longevity and prosperity, Elaia focuses on software technology companies. The firm is headquartered in Paris and manages Elaia Ventures, a French FCPR fund backed by financial institutions, industrial investors and family offices.
22
| Private Company | Investment Managers | 22 |
Mablink Bioscience
 Mablink Bioscience Pharmaceuticals: MajorHealth Technology Mablink Bioscience is a biotechnology company based in Lyon, France that develops next-generation antibody-drug conjugates for the treatment of solid tumors. Mablink Bioscience's exclusive PSarlink™ platform is a unique stealth technology that "masks" the hydrophobicity of the cytotoxic drugs by adding a polysarcosine chain to the linker. The French company's pipeline is built on the topoisomerase-I inhibitor exatecan as a payload for current developments. Recently, the company announced the publication of a review article titled “Payload Diversification\: A Key Step in the Development of Antibody–Drug Conjugates” which reviews the history of the successes and failures in ADC payloads and takes a look at the new roads currently explored by the industry. The company was founded in 2018 by Warren Viricel and Jean-Guillaume Lafay, with Jean-Guillaume Lafay serving as CEO since then.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Exeliom Biosciences
 Exeliom Biosciences BiotechnologyHealth Technology Nextbiotix SAS operates as clinical-stage Biopharmaceutical Company, which develops probiotics. The company was founded by Benjamin Hadida, Harry Sokol, Philippe Langella and Patrick Gervais in 2016 and is headquartered in Dijon, France.
5
| Holding Company | Biotechnology | 5 |
Cell-Easy SAS
 Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Ectycell SASU produces and sales stem cells. It offers pluripotent stem cells that can be used to develop drugs and model diseases. The company was founded in September 2009 and is headquartered in Romainville, France.
2
| Extinct | Biotechnology | 2 |
Bilhi Genetics SAS
 Bilhi Genetics SAS Pharmaceuticals: OtherHealth Technology Bilhi Genetics SAS specializes in the development of predictive medicines. It offers products for hepatic fibrosis and skin scars. The company was founded by David Sourdive and Pierre Dessein in June 2012 and is headquartered in Marseille, France.
1
| Holding Company | Pharmaceuticals: Other | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Sourdive via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SANOFI | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Corporate Officer/Principal | |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Auriga Partners SA
 Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Director/Board Member Private Equity Analyst | |
Domain Therapeutics SA
 Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member Director/Board Member | |
| MEDIAN TECHNOLOGIES | Medical/Nursing Services | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Graduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor | |
Availpro SAS
 Availpro SAS Other Consumer ServicesConsumer Services Availpro SAS provides online hotel reservation solutions. It offers a booking engine, which is integrated with a distribution tool, allowing the hoteliers to advertise and sell their rooms on third party websites. The company was founded by Philippe Jean Pierre Lamarche and Sébastien Maurice Boher on April 6, 2001 and is headquartered in Paris, France. | Other Consumer Services | Director/Board Member Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member President Director/Board Member | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member General Counsel Chief Executive Officer | |
| GENOMIC VISION | Medical Specialties | Director of Finance/CFO Chief Operating Officer | |
CYTOO SA
 CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
Convertigo SA
 Convertigo SA Packaged SoftwareTechnology Services Convertigo SAS provides Internet related software. It delivers a secured and scalable disruptive all-in-one solution, integrating rapid cross platform mobile development tools and a powerful MBaaS covering challenging backend enablement, featuring a middleware optimized for mobility. The company was founded by Olivier Picciotto and Jean-Michel Cohen in 1994 and is headquartered in Orsay, France. | Packaged Software | Director/Board Member Director/Board Member | |
eXo Platform SAS
 eXo Platform SAS Packaged SoftwareTechnology Services eXo Platform SAS provides information technology products and services. Its offers private cloud hosting, professional services, on-demand services, services packages, and training. The company was founded by Benjamin Mestrallet in 2003 and is headquartered in Paris, France. | Packaged Software | Director/Board Member Director/Board Member | |
Isocell SA
 Isocell SA Food RetailRetail Trade Isocell SA operates as a holding company with interests in the manufacture of food supplements. It develops proprietary formulation for super-oxyde dismutase. The firm also targets food areas including sodas, sport drinks and dairies with wellness claims. It also engages in the ownership and operations of medical laboratories. The company was founded by Francois Vix on July 9, 2001 and is headquartered in Paris, France. | Food Retail | Director/Board Member Director/Board Member | |
Aledia SAS
 Aledia SAS Electrical ProductsProducer Manufacturing Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France. | Electrical Products | Director/Board Member Director/Board Member | |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Fabentech SAS developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. Its products include infography development, Lassa(FBH-003) and other emerging diseases. The company was founded by Bertrand Lepine on June 5, 2009 and is headquartered in Lyon, France. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| NEOMA Business School | College/University | Undergraduate Degree Masters Business Admin | |
Hougou Développement SA
 Hougou Développement SA Financial ConglomeratesFinance Hougou Développement SA is an investment holding private company based in Ixelles, Belgium. The Belgian company's main function is to hold investments in other companies. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Pylote SA
 Pylote SA BiotechnologyHealth Technology Pylote SA conceives and develops mineral microspheres to sell solutions. Its products include mineral microspheres, material integration and pylote added. The company was founded by Loïc Marchin and is headquartered in Dremil-Lafage, France. | Biotechnology | Director/Board Member Director/Board Member | |
| Kotys SA | Director/Board Member Director/Board Member | ||
Keranova SA
 Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Medical Specialties | Director/Board Member Director/Board Member | |
EnobraQ SAS
 EnobraQ SAS Chemicals: Major DiversifiedProcess Industries EnobraQ SAS develops yeast for the production of chemical compounds. The company was founded on November 13, 2015 and is headquartered in Ramonville-Saint-Agne, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Nosopharm SAS
 Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Hougou Finance SA
 Hougou Finance SA Financial ConglomeratesFinance Hougou Finance SA is an investment holding Belgian company founded in 2016. The private company is based in Ixelles, Belgium. | Financial Conglomerates | Chairman Director/Board Member | |
MicroPEP Technologies SAS
 MicroPEP Technologies SAS Miscellaneous Commercial ServicesCommercial Services MicroPEP Technologies SAS engages in the development of biomimetic peptides that manage plant genetics. The company was founded by Thomas Laurent on April 15, 2016 and is headquartered in Toulouse, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The private company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman Chairman | |
GeneSpire Srl
 GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Director/Board Member Chief Executive Officer | |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Standing Ovation SAS
 Standing Ovation SAS Food: Meat/Fish/DairyConsumer Non-Durables Part of UNIBEL SA, Standing Ovation SAS is a French company that specializes in animal-free dairy cheese. The private company is based in Paris, France. Standing Ovation is focused on providing new solutions to environmental and ethical challenges. The company was founded in 2020 by Romain Chayot, Frédéric Pâques. Frédéric Pâques has been the CEO since 2020. Standing Ovation was acquired by Bel SA on November 15, 2022. | Food: Meat/Fish/Dairy | Chief Executive Officer President | |
| CELLNOVO | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| GLOBAL BIOENERGIES | Chemicals: Specialty | Chief Operating Officer Corporate Officer/Principal Director/Board Member | |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Biotechnology | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Frankrijk | 39 |
| Verenigde Staten | 5 |
| België | 3 |
| Italië | 3 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 5 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 282 |
| Corporate Officer/Principal | 109 |
| Chief Executive Officer | 47 |
| Chairman | 47 |
| Independent Dir/Board Member | 44 |
Sterkste connecties
| Insiders | |
|---|---|
| Alain Munoz | 38 |
| Florian Denis | 35 |
| Pierre Bastid | 29 |
| Franck Lescure | 28 |
| Jean-Pierre Garnier | 28 |
| Graziano Seghezzi | 26 |
| Mathieu Simon | 22 |
| Laurent Arthaud | 21 |
| Jean-Marie Messier | 18 |
| Marc Le Bozec | 16 |
| Sacha Loiseau | 15 |
| Elsy Boglioli Hofman | 14 |
| Valérie Calenda | 13 |
| Alain Godard | 12 |
| Rainer Boehm | 12 |
- Beurs
- Insiders
- David Sourdive
- Bedrijfsconnecties
